- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02151188
Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response
1. februar 2016 oppdatert av: Melvin Leow, Clinical Nutrition Research Centre, Singapore
This study hypothesizes that milk protein consumed together or shortly before a white rice or white bread carbohydrate meal exerts different influence on the glycaemic, insulinaemic responses.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Consumption of milk proteins increase satiety and reduce glucose response when consumed alone or with carbohydrate.
Milk proteins are of interest because proteins are more satiating than either carbohydrate or fat, and they regulate food intake and metabolic functions by the intact protein, encrypted peptides and amino acids on gastrointestinal and central pathways.
White rice and white bread are two common carbohydrates types mostly consumed in Asia.
Both of them are known to result in high glycaemic and insulinaemic responses.
However, in most meals, they are accompanied by other foods such as soy milk, cow milk products.
The glyceamic and insulinaemic responses are determined by the type of protein and the type of carbohydrates.
And also the consumption time of protein and carbohydrate.
Recent research points to an intrinsic value of small amounts of milk protein or dairy consumed shortly before a meal can reduce the glycemic response to carbohydrate and that this is not at the cost of increased demand for insulin.
The objective of the present study is to investigate how glycaemic, insulinaemic and satiety responses to a white rice or white bread meal changed when a soy milk or cow milk consumed together or shortly before the meal.
Whole soy milk and whole cow milk will be added to the meal.
Healthy subjects (n 15) will ingest the test meals once.
The meals will be provided as breakfasts, on 10 different occasions, in random order with ≥ 7 days between each.
Blood samples (from the cannula and finger pricks) will be then drawn for 3 h, and glucose and serum insulin, plasma glucagon, satiety markers, inflammation markers, amino acids et.al will be analysed.
The objective of the study is determining if different liquid protein consumed shortly before or with carbohydrate has different effects on metabolism.
And also we will compare the difference of white rice and white bread.
Determining the consuming time effect, milk protein type and carbohydrate type on glycaemic and insulinaemic are critical for the provision of dietary advice and formulation of public health guidelines.
Studietype
Intervensjonell
Registrering (Faktiske)
15
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Singapore, Singapore, 117599
- Clinical Nutrition Research Centre
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
21 år til 40 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Mann
Beskrivelse
Inclusion Criteria:
- Chinese ethnicity
- Age between 21-40 years
- Not on prescription medication known to affect glucose and satiety related metabolism
- Do not partake in sports at the competitive and/or endurance levels
- Weight of at least 45kg
- Body mass index between 18.0 to 24.9 kg/m2
- Normal blood pressure (120/80 mmHg)
Exclusion Criteria: Smoker
- fasting blood glucose>5.5 mmol/L
- Any major medical conditions including diabetes, hypertension, cardiovascular disease, thyroid disorders
- Allergic or intolerant to foods presented in the study
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Bread and water
co-ingestion control session
|
The study will examine the metabolic effects of two liquid proteins (soy milk and cow milk) with carbohydrate (bread) meals.
|
|
Eksperimentell: bread with cow milk co-ingestion
co-ingestion bread with cow milk
|
The study will examine the metabolic effects of two liquid proteins (soy milk and cow milk) with carbohydrate (bread) meals.
|
|
Eksperimentell: bread with soy milk co-ingestion
co-ingestion bread with soy milk
|
The study will examine the metabolic effects of two liquid proteins (soy milk and cow milk) with carbohydrate (bread) meals.
|
|
Eksperimentell: preload cow milk
preload cow milk 30 min, then bread
|
The study will examine the metabolic effects of two liquid proteins (soy milk and cow milk) with carbohydrate (bread) meals.
|
|
Eksperimentell: preload soy milk
preload soy milk 30 min, then bread
|
The study will examine the metabolic effects of two liquid proteins (soy milk and cow milk) with carbohydrate (bread) meals.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Glucose response of different treatments
Tidsramme: 3.5 hrs post consumption
|
The blood glucose will be measured by Hemocue 201 from finger prick.
Venous blood will be collected at the same time points.
|
3.5 hrs post consumption
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Gastric emptying rate
Tidsramme: 2 hours post consumption
|
Measurement of gastric emptying rate using real-time ultrasonography (GE LOGIQ P5 ultrasound in CNRC).
Ultrasound measurements will be taken with subjects in a supine position during fasting, then at 15-30 min intervals after consumption of the test meal.
|
2 hours post consumption
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. mars 2014
Primær fullføring (Faktiske)
1. oktober 2015
Studiet fullført (Faktiske)
1. oktober 2015
Datoer for studieregistrering
Først innsendt
28. mai 2014
Først innsendt som oppfylte QC-kriteriene
29. mai 2014
Først lagt ut (Anslag)
30. mai 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
2. februar 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
1. februar 2016
Sist bekreftet
1. februar 2016
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2014/00036
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .